Humana Inc. (NYSE: HUM) announced today that Jonathan Lord, M.D., Humana’s senior vice president and chief innovation officer, has been named chief executive officer of Navigenics, Inc., a Foster City, Calif.-based personal genomics company that uses DNA testing and analysis to determine an individual’s genetic predisposition for various health conditions with the goal of improving health outcomes in individuals across the population.
Dr. Lord, who joined Humana in 2000 as the company’s first chief innovation officer, will leave Humana and assume his new position May 1.
“As a physician-researcher and a hands-on health futurist, Jack Lord has become a global leader in health care innovation, promotion and prevention,” said Mike McCallister, president and chief executive officer of Humana. “For the past nine years, his work as the founding head of Humana’s Innovation Center has powerfully transformed the company and the entire health benefits industry.”
Among Dr. Lord’s accomplishments at Humana were the design and implementation of innovative products and services that enable consumers to choose, finance and use their health benefits with confidence and success, including SmartSuite health plans and the ground-breaking SmartSummary and SmartSummary Rx comprehensive benefits statements. In recent years, he and his team developed a number of industry-leading, consumer-focused health and wellness initiatives including HealthMiles, the Freewheelin bike-sharing program and Humana Games4Health.
Before coming to Humana, Dr. Lord was president of Health Dialog in Boston, where he helped pioneer e-enabled health care. He has also served as chief operating officer of the American Hospital Association in Washington, D.C., and is currently a member of the advisory committee to the director of the Centers for Disease Control in Atlanta.
McCallister said a successor to Dr. Lord would likely be named in the near future.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment